Xeris Biopharma Holdings Inc

NASDAQ:XERS   3:59:58 PM EDT
2.01
+0.06 (+2.82%)
Other Pre-Announcement

Xeris Biopharma Reports Third Quarter 2021 Financial Results And Other Highlights

Published: 11/10/2021 12:12 GMT
Xeris Biopharma Holdings Inc (XERS) - Xeris Biopharma Reports Third Quarter 2021 Financial Results and Other Highlights.
Sees FY Sales $38 Million to $40 Million.
Believes Cash Resources Sufficient to Sustain Operations Through at Least End of 2022.
Qtrly Net Loss per Common Share, Basic and Diluted$0.39.
Q3 Earnings per Share View $-0.37 -- Refinitiv Ibes Data (analyst estimates).